SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-090401
Filing Date
2021-07-08
Accepted
2021-07-08 21:53:05
Documents
2
Period of Report
2021-07-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2112802d6_form3.html 3  
1 FORM 3 tm2112802d6_form3.xml 3 3944
2 EXHIBIT 24 tm2112802d6_ex24.htm EX-24 8519
  Complete submission text file 0001104659-21-090401.txt   13859
Mailing Address C/O MARINA BIOTECH, INC. 17870 CASTLETON STREET, SUITE 250 CITY OF INDUSTRY CA 91748
Business Address
Calais Philippe (Reporting) CIK: 0001693728 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40363 | Film No.: 211081540

Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Issuer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations